Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. HOOD
8. DFTX
9. USO
10. RGNX

Go back to Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA
Eisai Co Ltd (AMEX: ESALF) Delayed: 25.00 --0 (-0%)
Previous Close $25.00    52 Week High $66.25 
Open $25.00    52 Week Low $53.50 
Day High $25.00    P/E N/A 
Day Low $25.00    EPS $0.00 
Volume 10       

Eisai Co Ltd American Depositary Shares (AMEX: ESALY) Delayed: 61.51 --0 (-0%)
Previous Close $61.51    52 Week High $67.60 
Open $49.73    52 Week Low $53.55 
Day High $61.51    P/E N/A 
Day Low $61.51    EPS $0.00 
Volume 1,907,007       

Merck & Co. (NYSE: MRK) Delayed: 115.11 +1.24 (1.09%)
Previous Close $113.87    52 Week High $65.46 
Open $113.97    52 Week Low $47.97 
Day High $115.56    P/E 78.31 
Day Low $113.00    EPS $1.47 
Volume 4,331,379